The Use of Automated Control of FiO2 in the NICU
In this webinar, Anton van Kaam, MD, PhD, and Dr. Tomasz Szczapa, MD, PhD, discuss oxygen supplementation, SpO2 targeting, the effects of hypoxia and hyperoxia, and review automated oxygen delivery systems and clinical evidence supporting their use. They also explore the need for further research to support these systems' implementation in the NICU.
Featured guest
Anton van Kaam, MD, PhD and Tomasz Szczapa, MD, PhD
Anton van Kaam, MD, PhD, is currently a professor of neonatology and the chief of the neonatal intensive care units at the Emma Children’s Hospital in the Academic Medical Center and the VU University Medical Center in Amsterdam, Netherlands.
Tomasz Szczapa, MD, PhD, is an Associate Professor and Head of the II Department of Neonatology at Poznań University of Medical Sciences in Poland. He also leads the Neonatal Biophysical Monitoring & Cardiopulmonary Therapies Research Unit. Dr. Szczapa's work focuses on advancing neonatal care through innovative research in biophysical monitoring and cardiopulmonary therapies. His leadership in both clinical and research settings contributes significantly to improving the health outcomes of neonates and training the next generation of medical professionals.
